Ju‐Chien Cheng

1.1k total citations
44 papers, 886 citations indexed

About

Ju‐Chien Cheng is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Ju‐Chien Cheng has authored 44 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Epidemiology and 11 papers in Hepatology. Recurrent topics in Ju‐Chien Cheng's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (6 papers) and Influenza Virus Research Studies (4 papers). Ju‐Chien Cheng is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (6 papers) and Influenza Virus Research Studies (4 papers). Ju‐Chien Cheng collaborates with scholars based in Taiwan, United States and Japan. Ju‐Chien Cheng's co-authors include Ching‐Ping Tseng, Chin‐Hsiao Tseng, Shan‐Chwen Chang, Ming‐Fu Chang, Naoya Sakamoto, Sheng‐Da Hsu, Hsien‐Da Huang, Yu‐Ling Chang, Choon‐Khim Chong and Kowit‐Yu Chong and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Ju‐Chien Cheng

42 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju‐Chien Cheng Taiwan 17 388 174 166 141 124 44 886
Yalin Li China 16 262 0.7× 118 0.7× 73 0.4× 64 0.5× 50 0.4× 58 796
Dandan Zhou China 11 378 1.0× 304 1.7× 316 1.9× 149 1.1× 72 0.6× 16 998
Wenjing Zai China 16 350 0.9× 251 1.4× 121 0.7× 56 0.4× 72 0.6× 26 712
Jianhong Chen China 16 188 0.5× 208 1.2× 81 0.5× 67 0.5× 53 0.4× 58 680
KyeongJin Kim South Korea 20 525 1.4× 595 3.4× 378 2.3× 118 0.8× 114 0.9× 37 1.3k
Shengdi Wu China 17 354 0.9× 390 2.2× 282 1.7× 92 0.7× 122 1.0× 44 1.1k
Theodor Kudlich Germany 12 207 0.5× 283 1.6× 88 0.5× 52 0.4× 140 1.1× 23 806
Jee Eun Kim South Korea 17 322 0.8× 192 1.1× 67 0.4× 43 0.3× 68 0.5× 38 1.1k
Haiming Zhang China 14 191 0.5× 259 1.5× 122 0.7× 83 0.6× 56 0.5× 60 769
Jin Ha Lee South Korea 16 377 1.0× 209 1.2× 75 0.5× 61 0.4× 220 1.8× 29 837

Countries citing papers authored by Ju‐Chien Cheng

Since Specialization
Citations

This map shows the geographic impact of Ju‐Chien Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Chien Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Chien Cheng more than expected).

Fields of papers citing papers by Ju‐Chien Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju‐Chien Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Chien Cheng. The network helps show where Ju‐Chien Cheng may publish in the future.

Co-authorship network of co-authors of Ju‐Chien Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ju‐Chien Cheng. A scholar is included among the top collaborators of Ju‐Chien Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju‐Chien Cheng. Ju‐Chien Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, C. Kiong, Hui-Ju Tsai, Jinru Wang, et al.. (2025). Development of PowerMag System II for Isolation of Circulating Tumor Cells with Improved Purity. Biomedicines. 13(2). 431–431.
2.
Liu, Ju‐Fang, et al.. (2024). Discovery of Novel Spike Inhibitors against SARS-CoV-2 Infection. International Journal of Molecular Sciences. 25(11). 6105–6105. 2 indexed citations
3.
Kuo, Chao‐Lin, et al.. (2024). Solanum torvum induces ferroptosis to suppress hepatocellular carcinoma. Journal of Ethnopharmacology. 335. 118670–118670. 2 indexed citations
5.
Chao, Tai‐Ling, Sui‐Yuan Chang, Chih‐Hao Lu, et al.. (2023). Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry. International Journal of Molecular Sciences. 24(23). 17040–17040. 3 indexed citations
6.
Lu, Chih‐Hao, et al.. (2022). In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction. Scientific Reports. 12(1). 303–303. 12 indexed citations
7.
Tsai, Hui-Ju, Ju‐Chien Cheng, Yi‐Hsuan Chiang, et al.. (2021). Integrin αIIbβ3 outside-in signaling activates human platelets through serine 24 phosphorylation of Disabled-2. Cell & Bioscience. 11(1). 32–32. 4 indexed citations
8.
Tseng, Ching‐Ping, et al.. (2020). Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection. Journal of Virology. 95(4). 12 indexed citations
9.
Liu, Chien-Ting, Yu‐Li Su, Cheng‐Hsu Wang, et al.. (2020). Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response. Journal of Clinical Medicine. 9(1). 188–188. 19 indexed citations
11.
Cheng, Ju‐Chien, et al.. (2019). Antiviral activity of Portulaca oleracea L. against influenza A viruses. Journal of Ethnopharmacology. 241. 112013–112013. 37 indexed citations
12.
Tseng, Ching‐Ping, et al.. (2013). Hepatitis C Virus Replication Is Modulated by the Interaction of Nonstructural Protein NS5B and Fatty Acid Synthase. Journal of Virology. 87(9). 4994–5004. 54 indexed citations
13.
Chu, Hui‐Chun, et al.. (2013). Erythroid differentiation is augmented in Reelin‐deficient K562 cells and homozygous reeler mice. FEBS Letters. 588(1). 58–64. 9 indexed citations
14.
Cheng, Ju‐Chien, Ching‐Ping Tseng, Sheng‐Da Hsu, et al.. (2012). Let-7b is a novel regulator of hepatitis C virus replication. Cellular and Molecular Life Sciences. 69(15). 2621–2633. 95 indexed citations
15.
Huang, Chien‐Ling, Ju‐Chien Cheng, Kenji Kitajima, et al.. (2010). Disabled‐2 is required for mesoderm differentiation of murine embryonic stem cells. Journal of Cellular Physiology. 225(1). 92–105. 17 indexed citations
16.
Lin, Jih‐Hui, et al.. (2010). Molecular epidemiology and antigenic analyses of influenza A viruses H3N2 in Taiwan. Clinical Microbiology and Infection. 17(2). 214–222. 8 indexed citations
17.
Wang, Sheng‐Yang, Ching‐Ping Tseng, Keng‐Chang Tsai, et al.. (2009). Bioactivity-guided screening identifies pheophytin a as a potent anti-hepatitis C virus compound from Lonicera hypoglauca Miq.. Biochemical and Biophysical Research Communications. 385(2). 230–235. 37 indexed citations
18.
Tseng, Chin‐Hsiao, Choon‐Khim Chong, Ching‐Ping Tseng, et al.. (2007). Mortality, causes of death and associated risk factors in a cohort of diabetic patients after lower-extremity amputation: A 6.5-year follow-up study in Taiwan. Atherosclerosis. 197(1). 111–117. 32 indexed citations
19.
Tseng, Chin‐Hsiao, Ching‐Ping Tseng, Tzu‐Pi Huang, et al.. (2006). Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia. 49(8). 1755–1760. 101 indexed citations
20.
Chen, Chao‐Hsien, et al.. (2005). A gene cluster for the fatty acid catabolism from Pseudonocardia autotrophica BCRC12444. Biochemical and Biophysical Research Communications. 329(3). 863–868. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026